<DOC>
	<DOCNO>NCT00205634</DOCNO>
	<brief_summary>The purpose study evaluate whether Biaxin ( clarithromycin ) improve sputum abnormality , lung function , overall feeling well-being people cystic fibrosis ( CF ) . Biaxin antibiotic commonly use treatment respiratory infection people CF , sometimes used CF patient well . Studies do disease call diffuse panbronchiolitis ( similar CF ) preliminary study do CF patient suggest Biaxin might beneficial effect CF sputum way unrelated antibiotic activity .</brief_summary>
	<brief_title>Macrolide Antibiotic Therapy Patients With Cystic Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<criteria>diagnosis CF ability reliably perform spirometry FEV1 30 % predicted time screen Mycobacterium sputum culture ever record respiratory exacerbation require IV antibiotic 60 day prior used investigational drug device 60 day prior significant ( &gt; 30ml ) hemoptysis past year require oxygen significant liver renal disease</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Cystic Fibrosis ( CF )</keyword>
	<keyword>Macrolide antiobiotics</keyword>
	<keyword>airway inflammation</keyword>
</DOC>